Ramanan Laxminarayan “Using Value of Statistical Life (VSL) Measures in Vaccine Priority Setting” IVIR, World Health Organization, Geneva (Sep. 2012) “Economic Evaluation of Financial Instruments for Influencing Uptake of Health Interventions” Indian Statistical Institute, Department of Economics, New Delhi (Aug. 2012) “Setting Disease Control Priorities in Developing Countries,” First Annual Conference of the Health Economics Association of India, New Delhi (Apr. 2012) “Best Buys in Delivery: Examples from Routine Immunization and Malaria” Briefing for Bill Gates, Seattle (Feb. 2012) “The Global Context for Financing Delivery Innovations in Fever Case Management and Malaria Treatment,” World Bank, Washington DC (Dec. 2011) “Transboundary Problems in Infectious Diseases,” UCI conference on Mathematical Modeling of Infectious Diseases: Bridging data and models, Irvine (Oct.2011) “Disease Burden Estimation for Communicable Diseases,” National Center for Disease Control, New Delhi (Jul. 2011) “Ensuring Effective Antibiotics in the 21st Century”, World Health Organization, Geneva (Jun. 2011) “India’s Vaccine Deficit”, Health Affairs Briefing on the Decade of Vaccines, Washington DC (Jun. 2011) “Economics of Infectious Diseases”, George Washington University School of Public Health, Washington DC (Mar. 2011) “Economics of Disease in Motion”, Princeton Workshop on Disease in Motion, Princeton NJ (Feb. 2011) “The Drug Resistance Index”, Annual Meetings of the American Society for Tropical Medicine and Hygiene, Atlanta (Nov. 2010) “Extending the Cure: Challenges in Ensuring Effective Antibiotics in the 21st Century” The Society of Infectious Diseases Pharmacists Annual Meeting, Boston (Sep. 2010) “Perspectives on Rational Use and Access”, Conference on the Global Need for Effective Antibiotics, Uppsala, Sweden (Sept. 2010)
“Transboundary problems in infectious diseases” Fields Institute, Toronto, Ontario, Canada (Jul. 2010) “The Growing Problem of Multidrug-‐Resistant Bacteria in Developing Countries” International Conference on Emerging Infectious Diseases, Atlanta (Jul. 2010)
-16-